ARTICLE
30 December 2020

New Court Proceedings - December 2020

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
REVLIMID (lenalidomide): Celgene v Taro.
Canada Litigation, Mediation & Arbitration

PMNOC Proceedings:

  • REVLIMID (lenalidomide): Celgene v Taro
  • COPAXONE (glatiramer acetate injection): Teva v Mylan

Judicial Review Proceedings:

  • KEYTRUDA (pembrolizumab): Merck v The Minister of Health

For complete details about these proceedings, click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More